loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 2024233 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN INJECTION HUMAN BIOSYNTHETIC (1)

filter

01 NOVO NORDISK CANADA INC (1)

filter

01 SOLUTION (1)

filter

01 100UNIT/ML (1)

filter

01 Canada (1)

URL Supplier Web Content
SOLUTION
100UNIT/ML
NOVOLIN GE TORONTO
Canada
2024233
10ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2024233

Looking for CTD TGA MCC DOSSIER APPLICATION 2024233 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN INJECTION HUMAN BIOSYNTHETIC, with a corresponding application number 2024233 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLIN GE TORONTO SOLUTION, medication with 100UNIT/ML of INSULIN INJECTION HUMAN BIOSYNTHETIC.

Post Enquiry
POST ENQUIRY